New cell imaging method identifies aggressive cancer cells early
Fluorescence that illuminates a specific protein within a cells nucleus may be a key to identifying cancer virulence and to developing individualized treatment, according to researchers at Purdue University and Lawrence Berkeley National Laboratory.
The scientists created a technique that automatically locates and maps proteins involved in regulating cell behavior, said Sophie Lelièvre, Purdue assistant professor of basic medical sciences. The research results have for the first time made it possible to verify the distinction between multiplying cells that are harmless and those that are malignant.
Lelièvre and co-corresponding author on the study, David Knowles of the national lab, used human mammary cells to analyze nuclear protein distribution that shifted depending on whether a cell was malignant, had not yet developed a specific function or was a normally functioning mature mammary cell.
“When you look at cells that dont yet have a specific function – aren’t differentiated, compared to fully differentiated cells, which are now capable of functioning as breast cells – the organization of proteins in the nucleus varies tremendously,” Lelièvre said. “Then looking at how the proteins in malignant cells are distributed, its a totally different pattern compared to normal differentiated cells.”
The research teams study on the imaging technique and its use in 3-D mapping and analysis of nuclear protein distribution is published this week online in Proceedings of the National Academy of Sciences. Ultimately, the scientists want to use the technique to determine not only if a lesion is malignant but also the exact kind of cancer, how likely it is to spread and the most appropriate treatment for a particular patient.
“The major problem exists in the pre-malignant stages of abnormal cells in determining whether cancer will develop, what type and how invasive it will be,” Lelièvre said. “The decision then is whether to treat or not to treat and how to proceed in these preliminary stages because only a certain percentage of these patients will ultimately develop cancer.
“We want to use this technique to identify subtypes of cells within lesions that potentially could become more aggressive forms of cancer.”
Lelièvre, Knowles and their team used an antibody attached to a fluorescent molecule that targeted and linked with a specific nuclear protein from mammary tissue. When malfunctioning, this protein, named nuclear mitotic apparatus protein (NuMA), has been linked to leukemia and breast cancer.
The imaging technique the researchers developed to identify NuMA location shifts is called an automated local bright feature image analysis. It recorded the average amount of luminescence throughout the nucleus and then located the brightest spots, which were the protein. The system then automatically measured the differences in the proteins distribution in each cell type and mapped it. This enabled the researchers to verify the changes exhibited by non-differentiated cells that were still multiplying, normal mammary cells and multiplying malignant cells.
The ability to see the protein patterns in the nucleus gives scientists one more tool in advancing the identification of types of cancer and appropriate treatment, Lelièvre said. The imaging tool should work for mapping and analyzing locations of any nuclear protein.
“We have genomics and proteomics that tell us about where genes are, whether they are functioning and interactions of genes with proteins, but no one had focused on the changing distribution of nuclear proteins,” she said. “Looking at the location of the proteins is a third part of studying cancer.
“We call it architectural proteomics because the proteins are still there but the location changes.”
These protein shifts in the nucleus also may change the protein function, Lelièvre said. The new technique to map protein location will help determine this as well. In the case of malignant cells, it may reveal what signaling process went awry causing abnormal cell growth.
“Its as if, instead of losing an arm, your arm was placed in another location. Its abnormal, but you have everything you need – just not in the right place,” she said. “Its what happens in cancer, too; the needed proteins are still there but not in the right place anymore, so their function is altered.”
The misplaced proteins in their new locations change how the cell behaves and participate in the promotion of cancer, she said. Being able to measure the protein location shifts to aid in determining their function in cancer cell development will allow scientists to use the proteins as treatment targets.
“With our new system, we now will be able to look at individual cells and nuclei and possibly identify some classes of cells that could be more dangerous than others,” Lelièvre said.
The other researchers on the study were Carol Bator-Kelly, Purdue Department of Biological Science, and Damir Sudar and Mina Bissell, at the National Laboratorys Life Sciences Division Biophysics and Cancer Biology departments.
Lelièvre is also a member of Purdue’s National Cancer Institute-designated Cancer Center and Purdue’s Oncological Science Center at Discovery Park.
Funding for this research came from the Department of Defense Breast Cancer Research Program, the Department of Energy Office of Health and Environmental Research, the Walther Cancer Institute, “Friends you Can Count On” and the Purdue University Research Foundation.
Writer: Susan A. Steeves, (765) 496-7481, ssteeves@purdue.edu
Source: Sophie Lelièvre, (765)-496-7793, lelièvre@purdue.edu
Ag Communications: (765) 494-2722; Beth Forbes, forbes@purdue.edu
Agriculture News Page
Media Contact
More Information:
http://www.purdue.eduAll latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…